Centrifugal Blood Pumps Market By Product Type (Blood Pumping Systems, Heart-Lung Machines), By Type (Disposable, Reusable), By Application (Cardiovascular Surgery, Heart Failure Treatment, Emergency Surgery, Long-Term Cardiovascular Care), By End-User (Hospitals, Cardiac Surgery Centers, Other Surgical Centers, Home Care), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Centrifugal Blood Pumps Market was valued at USD 1.6 billion in 2024-e and will surpass USD 3.2 billion by 2030; growing at a CAGR of 12.8% during 2025 - 2030.

The centrifugal blood pumps market is experiencing significant growth due to increasing prevalence of cardiovascular diseases, rising demand for advanced surgical solutions, and advancements in medical technology. These devices play a critical role in maintaining blood circulation during surgeries such as open-heart procedures, ECMO therapy, and other critical care applications. With their ability to ensure consistent blood flow and minimize complications like hemolysis, centrifugal blood pumps have become indispensable in healthcare systems globally.

Additionally, the market benefits from the adoption of innovative features, including improved biocompatibility and user-friendly designs, which enhance operational efficiency. The growing focus on minimally invasive surgeries and the increasing need for extracorporeal life support systems further contribute to the expanding market.

Blood Pumping Systems Is Largest Product Type Due to Wide Usage in Surgical Procedures

The blood pumping systems segment holds the largest share in the centrifugal blood pumps market, primarily due to their widespread use in cardiovascular surgeries and critical care. These systems are integral components of extracorporeal circulation setups, helping to ensure uninterrupted blood flow during procedures like coronary artery bypass grafting (CABG), heart transplants, and ECMO therapy. Their ability to mimic the natural flow of blood reduces complications and enhances patient safety.

Advancements in blood pumping systems, such as improved hemodynamic performance, biocompatibility, and reduced risk of hemolysis, have further contributed to their dominance. As surgical centers and hospitals increasingly prioritize reliable and efficient solutions, the demand for blood pumping systems is expected to grow steadily in the coming years.

Disposable Type Is Largest Due to Cost-Effectiveness and Reduced Contamination Risk

The Disposable type segment dominates the centrifugal blood pumps market, primarily due to its cost-effectiveness and ability to mitigate the risk of cross-contamination. Disposable centrifugal blood pumps are widely used in critical care settings, including cardiovascular surgeries and ECMO, as they ensure sterility and eliminate the need for repeated sterilization processes. These pumps are particularly beneficial in high-demand healthcare facilities, where quick turnaround times and patient safety are paramount.

Moreover, advancements in disposable pump designs, such as improved flow dynamics and biocompatible materials, have significantly enhanced their performance and reliability. As hospitals and surgical centers prioritize infection control and operational efficiency, the demand for disposable centrifugal blood pumps is expected to remain strong in the coming years.

Cardiovascular Surgery Is the Largest Application Owing to High Procedure Volume

Cardiovascular surgery holds the largest share in the centrifugal blood pumps market, driven by the growing prevalence of heart diseases and the increasing number of surgical interventions. These pumps are critical in supporting blood circulation during procedures such as valve replacements, bypass surgeries, and heart transplants, where the heart must be temporarily stopped. The precision and reliability offered by centrifugal blood pumps make them an essential tool for cardiovascular surgeons.

Additionally, advancements in surgical techniques and the integration of centrifugal pumps with ECMO systems have further boosted their adoption. The rising global burden of cardiovascular diseases, combined with increasing investments in healthcare infrastructure, ensures continued demand for these devices in cardiovascular surgeries.

Hospitals Are the Largest End-User Owing to Advanced Infrastructure

Hospitals are the largest end-user segment in the centrifugal blood pumps market, owing to their ability to handle high volumes of complex surgical procedures. Equipped with state-of-the-art technology and highly skilled professionals, hospitals rely heavily on centrifugal blood pumps for life-saving applications. These devices are integral to operating rooms, critical care units, and specialized cardiac centers, ensuring patient safety during critical procedures.

The presence of advanced infrastructure and comprehensive patient care facilities makes hospitals the primary adopters of centrifugal blood pumps. As the demand for efficient and reliable surgical solutions grows, hospitals are expected to maintain their dominance in this market segment.

North America Is the Largest Market Owing to High Prevalence of Cardiovascular Diseases

North America leads the centrifugal blood pumps market, primarily due to the high prevalence of cardiovascular diseases and the availability of advanced healthcare facilities. The United States, in particular, contributes significantly to the market, with its robust healthcare infrastructure and growing number of cardiovascular surgeries. Favorable government initiatives and investments in research and development further support the market’s growth in the region.

The adoption of innovative technologies, such as disposable and biocompatible pumps, also drives the North American market. With an aging population and increasing awareness of cardiovascular health, the region is expected to maintain its leadership in the global centrifugal blood pumps market.

Leading Companies and Competitive Landscape

The centrifugal blood pumps market is highly competitive, with key players focusing on innovation and strategic collaborations to strengthen their positions. Prominent companies like Medtronic, Abbott Laboratories, Terumo Corporation, and LivaNova PLC are investing heavily in research and development to introduce advanced products with enhanced safety and efficiency features.

These companies are also leveraging partnerships with healthcare providers to expand their market presence. With a focus on product differentiation and improved patient outcomes, the competitive landscape is expected to see continued advancements and new product launches. Players that prioritize affordability and accessibility alongside innovation will emerge as leaders in the evolving market.

Recent Developments:

• In November 2024, Abbott Laboratories launched a next-generation centrifugal blood pump with advanced flow control for better patient outcomes in heart surgeries.
• In October 2024, Medtronic PLC introduced a new heart-lung machine model, featuring integrated centrifugal pumps and improved monitoring capabilities.
• In September 2024, Terumo Corporation announced the expansion of its centrifugal blood pump portfolio with the launch of a fully automated device for cardiac surgeries.
• In August 2024, Fresenius Medical Care AG & Co. KGaA upgraded its centrifugal blood pump line, incorporating real-time patient data analytics for better treatment planning.
• In July 2024, LivaNova PLC received FDA approval for its new centrifugal blood pump designed specifically for long-term heart failure management.

List of Leading Companies:

• Abbott Laboratories
• Medtronic PLC
• Fresenius Medical Care AG & Co. KGaA
• Getinge AB
• LivaNova PLC
• Terumo Corporation
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• BiVACOR Inc.
• SynCardia Systems, LLC
• C.R. Bard, Inc.
• Nihon Kohden Corporation
• Thoratec Corporation
• St. Jude Medical, Inc.
• Cardiomedics, Inc.

Report Scope: